Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Europace. 2012 Apr;14(4):522-7. doi: 10.1093/europace/eur313. Epub 2011 Oct 4.
Post-operative atrial tachyarrhythmias (AT) in patients with tetralogy of Fallot (ToF) are associated with congestive heart failure, stroke, and cardiac death. Effective treatment is therefore essential. The aim of the study is to evaluate long-term outcome of ablative therapy of AT in ToF patients and to study characteristics of AT recurrences.
Tetralogy of Fallot patients (N = 38, age 43 ± 12 years) referred for ablation of post-operative AT, appearing 26 ± 10 years after complete repair, were studied. Electro-anatomical/entrainment mapping was performed prior to ablation. Successful ablation was defined as (i) achievement of bi-directional conduction block for isthmus-dependent atrial flutter (IDAF), (ii) termination during ablation for intra-atrial reentrant tachycardia (IART) and focal atrial tachycardia (FAT). Fifty-two AT were ablated, including 37 IDAF [cycle length (CL) 294 ± 70 ms], 11 IART (CL 295 ± 46 ms), and 4 FAT (CL 371 ± 93 ms). Ablation was successful in 98%. Fifty-one of 52 AT involved the cavo-tricuspid isthmus and/or the area between scar tissue related to prior atriotomy incisions and the inferior caval vein. Multiple AT developed in 11 patients, with different mechanisms in 9. After 45 ± 24 months, 32 patients were in sinus rhythm; 5 used anti-arrhythmic drugs.
Ablative therapy of AT in ToF patients is an effective curative treatment modality with a high procedural success rate. Sinus rhythm during long-term follow-up was obtained in the majority of patients. Fifty-one of 52 AT originated from sites related to surgical incisions created at complete repair, suggesting that extending the atriotomy incision towards the inferior caval vein during cardiac surgery combined with surgical ablation of the cavo-tricuspid isthmus will be effective in preventing development of AT.
法洛四联症(ToF)患者术后房性心动过速(AT)与充血性心力衰竭、中风和心脏性死亡有关。因此,有效的治疗是必不可少的。本研究旨在评估 ToF 患者消融治疗 AT 的长期疗效,并研究 AT 复发的特征。
研究了 38 例因术后 AT 而接受消融治疗的 ToF 患者(年龄 43 ± 12 岁),这些患者在完全修复后 26 ± 10 年出现 AT。在消融前进行了电解剖/拖带映射。成功消融定义为:(i)峡部依赖性房扑(IDAF)的双向传导阻滞,(ii)消融期间终止的房内折返性心动过速(IART)和局灶性房性心动过速(FAT)。消融了 52 次 AT,包括 37 次 IDAF[周长(CL)294 ± 70 ms]、11 次 IART(CL 295 ± 46 ms)和 4 次 FAT(CL 371 ± 93 ms)。消融成功率为 98%。52 次 AT 中有 51 次涉及腔静脉-三尖瓣峡部和/或与先前房间隔切开术和下腔静脉相关的瘢痕组织之间的区域。11 例患者出现多个 AT,其中 9 例存在不同的机制。45 ± 24 个月后,32 例患者为窦性心律;5 例使用抗心律失常药物。
ToF 患者的 AT 消融治疗是一种有效的治疗方法,具有较高的手术成功率。大多数患者在长期随访中获得窦性心律。52 次 AT 中有 51 次起源于完全修复时的手术切口相关部位,提示在心脏手术中扩大房间隔切开术并结合腔静脉-三尖瓣峡部的外科消融将有效预防 AT 的发生。